REGISTER FOR SOSV’s VC-Founder Therapeutics Matchup July 13-17

Convalesce Inc

Stem cell therapy for neurodegenerative diseases

Company details

Convalesce is a therapeutic company enabling stem cell-based therapy for neurodegenerative conditions like Parkinson’s, harnessing state-of-art biomaterials. Our vision is to transform regenerative medicine for neurological conditions by combining stem cells and brain mimetic implantable biomaterials that will regenerate lost neurons and restore neural pathways.

According to Deloitte, on a global basis there has been 15% annual growth in cell and gene therapy companies over the last 3 years

Convalesce Inc Quote Image
Subhadeep Das, PhD, CEO
Our company will make cell and gene therapy more accessible, by providing a programmable environment for our own body to become a drug factory.

Team

Subhadeep Das

CEO & Co-Founder

Amrutraj Zade

Co-Founder

Get In Touch with Convalesce Inc

Please tell us a little bit about yourself and why you'd like to get connected. Convalesce Inc + SOSV will follow up with you via email.

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.